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Background Epigenetic programming and epigenetic mechanisms driven by environmental factors are thought to play an important role in human health and ageing. Global DNA methylation has been postulated as an epigenetic marker for epidemiological studies as it is reflective of changes in gene expression linked to disease. How epigenetic mechanisms are affected by psychological, sociological and biological determinants of health still remains unclear. The aim of this study was to investigate the relationship between socio-economic and lifestyle factors and epigenetic status, as measured by global DNA methylation content, in the pSoBid cohort, which is characterized by an extreme socio-economic and health gradient.
Methods DNA was extracted from peripheral blood leukocytes using the Maxwell Õ 16 System and Maxwell Õ 16 Blood DNA Purification kit (Promega, UK). Global DNA methylation was assessed using Methylamp TM Global DNA Methylation Quantification Ultra kit (Epigentek, USA). Associations between global DNA methylation and socio-economic and lifestyle factors were investigated in linear regression models.
Results
Global DNA hypomethylation was observed in the most socio-economically deprived subjects. Job status demonstrated a similar relationship, with manual workers having 24% lower DNA methylation content than non-manual. Additionally, associations were found between global DNA methylation content and biomarkers of cardiovascular disease (CVD) and inflammation, including fibrinogen and interleukin-6 (IL-6), after adjustment for socio-economic factors.
Introduction
DNA methylation is an important epigenetic mechanism involved in the regulation of gene expression, genomic stability and imprinting during embryogenesis. 1 It may also constitute a novel bio-dosimeter with which to examine the impact of socio-economic and lifestyle factors on disease susceptibility and risk.
Changes in global DNA methylation may be some of the earliest cellular events in disease onset. 2 Aberrant DNA methylation has been linked to ageing and a broad range of diseases including cardiovascular and neuronal disorders, as well as cancer. 3 DNA methylation is crucial for mammalian development/differentiation and the pattern of this DNA modification is established during embryogenesis, beginning with embryo implantation (global demethylation) followed by de novo re-methylation before organogenesis commences. The methylation pattern becomes imprinted in early life leading to predisposition for specific chronic diseases; however changes can still be made although these are usually minor and can occur throughout adulthood. 1 DNA methylation changes have also been linked to the ageing process, with chronological ageing being accompanied by gradual genome hypomethylation, but with an increase of methylation occurring within promoter regions. 4 The pattern of methylation within specific genomic regions may be altered in response to diet and lifestyle factors, such as cigarette smoking. 4, 5 Recent studies have shown that dietary factors, in particular, may be involved in the regulation of global DNA methylation during embryogenesis and this may have further consequences in adult life. 1 Insufficient maternal care or diet can be reflected in the methylation status of their offspring. Indeed, an inherited sensitivity to stress, influenced by the mood of the mother during pregnancy, has also been reported. 6 These observations suggest that there may be an adaptive mechanism which allows for epigenetic plasticity in response to environmental changes. A broad range of environmental factors may therefore impact on global DNA methylation status and consequently health. This is important to the understanding of the impact of socio-economic drivers of ill health, which may be predominant in communities where there is also a higher prevalence of classical risk factors for disease.
One hypothesis for the increased disease prevalence in these communities is underlying chronic inflammation, a component linked to a wide range of pathologies. 7 This, however, may be influenced by epigenetic reprogramming, with consequential transcriptome remodelling in the aetiology of chronic inflammatory diseases. 8 We and others have previously reported a strong association between inflammatory biomarkers, such as C-reactive protein and interleukin-6 (IL-6), and DNA methylation in chronic kidney disease patients. 9, 10 At a mechanistic level, inflammation has a direct impact on the activity of enzymes involved in the establishment, maintenance and change of epigenetic status. In particular, IL-6 is involved in the regulation and localization of HDNMT (human DNA methyltransferase), 11, 12 influencing expression and activity of this enzyme. Consequently, increased inflammation may lead to aberrant methylation leading to subsequent ill health. 13 These observations, in toto, are of particular relevance to Glasgow because of the associated variation in mortality, morbidity and the extreme socio-economic (SE) gradient of health inequality in this city which is not fully explained by conventional risk factors for disease. 14 The aim of this study was to enhance our understanding of the relationship between epigenetic status and underlying associations between socio-economic factors and risk factors for ill health, using the Glasgow-based pSoBid cohort.
Rather than using a high resolution analysis of methylation patterns associated with transcriptional changes, we have determined epigenetic status simply by measuring global methylation content and investigated whether we could use this to explain the difference in prevalence of ill health between most and least deprived groups in this cohort. Our working hypothesis was that social deprivation would be associated with genome-wide hypomethylation (i.e. reduced methylation content), which would in turn be associated with enhanced inflammatory status and associated disease risk.
Methods
Study population
Participants comprised a subset (n ¼ 239) of the original pSoBid cohort, for which sufficient quantity and quality DNA was available for analysis, 15 as determined by spectral analysis. The design of the psychological, social and biological determinants of ill health (pSoBid) study has been described in detail elsewhere. 12 In brief, participants were ranked on the basis of multiple deprivation indicators to define the least and most deprived areas in the NHS Greater Glasgow Health Board area, using criteria based on the Scottish Index for Multiple Deprivation (SIMD). Sampling was stratified to achieve an approximately equal distribution of the 666 participants across males and females and age groups (35-44, 45-54 and 55-64 years) within the most (bottom 5% of SIMD score) and least deprived areas (top 20% of SIMD score). From this original population 239 individual DNA samples were available for analysis. Supplementary  Table S1 compares these 239 participants with the 427 who were not included with respect to age, gender, deprivation group, social class, income, education, housing tenure, smoking habit, diet, alcohol consumption, body mass index and waist/hip ratio. Only age group and waist/hip ratio differed between included and excluded participants, there being a lower proportion of 55 to 64-year-olds in the included participants (29% compared with 45%) and a higher mean waist/hip ratio (0.91 compared with 0.89). These samples were blinded with only the provision of an ID number to identify each individual sample, the samples were analysed and data were sent for unblinding to statistical core where statistical analysis was completed. Participants were assessed, with physical examination data, medical history, risk factors, arteriosclerosis indicators (plaque count, carotid intima-media thickness), cognitive functions analysis, morbidity and psychological profiles being collected.
Global DNA methylation determination DNA was extracted from peripheral blood leukocytes using Maxwell Õ 16 System and Maxwell Õ 16 Blood DNA Purification kit (Promega). Quantitative and qualitative DNA analysis was performed using Nanodrop. DNA was analysed for global methylation using Methylamp TM Global DNA Methylation Quantification Ultra kit (Epigentek, USA) according to the manufacturer's instructions. The capture antibody in this kit binds to 5-methylcytosine, thus measuring total DNA methylation level as a percentage of total DNA present in the sample. Hence it measures global DNA content, not specific sites, patterns or methylation types, as other systems do. Samples were run in duplicate and a standard curve was run in triplicate as were the positive and negative controls. Inter-assay precision (%CV) was <8%, intra-assay %CV was <6.5%.
Briefly, the plate was coated with 200 ng of DNA (100 ng/ml) per well and dried at 378C for 40 min followed by incubation at 608C until the solution evaporated and wells were dried. Simultaneously, the standard curve (range 0.2-20 ng of methylated DNA) and negative control DNA were prepared for each plate. The amount of methylated DNA (pg) was determined according to manufacturer's instruction; additionally %DNA methylation was calculated.
Statistical analysis
Associations between DNA methylation (expressed as a percentage of total DNA by weight) and participant characteristics were investigated in linear regression models adjusted for the stratification variables: age group (35-44, 45-54 and 55-64 years), gender (male and female) and deprivation group (bottom 5% and top 20% of SIMD score). Failure to adjust for these variables would risk uncovering spurious associations, in particular with lifestyle and socio-economic status (SES) factors, which are likely to be closely correlated with deprivation group. DNA methylation content and biomarkers were log transformed to satisfy the assumption of normally distributed residuals. Primary analyses were focused on the associations between methylation and factors reflecting SES and lifestyle. Firstly, the association between methylation and deprivation group was assessed because deprivation was the primary focus of the pSoBid study and drove the sampling strategy. Other factors reflecting SES were added separately to this base model (containing age group, gender and deprivation group), yielding a subset of SES factors that were associated with global DNA methylation. These factors were combined in a single model to assess which factors were independently associated with methylation. Secondly, we assessed the associations between DNA methylation and specific biomarkers associated with biological ageing and cardiovascular disease (CVD) by including DNA methylation as a covariate in linear regression models for each biomarker with adjustment for age, gender and deprivation group. Finally, interactions were tested between SES and age group (when the outcome variable was global DNA methylation) and methylation and age group (when the outcome was biomarker level). This study was exploratory, therefore no adjustment for multiple testing has been made. We detected a negative association between sampling date and DNA methylation content, which was not explained by any of the stratification variables (age group, gender and deprivation group). However, adjusting for sampling date had a negligible effect on the results presented here.
Percentage global DNA methylation and biomarker levels were log transformed for regression analysis. Regression coefficient estimates were therefore multiplicative when transformed back to the original scale, and are presented as the percentage difference in global DNA methylation associated with each patient characteristic where global methylation is the outcome, and percentage difference in biomarker level associated with a standard deviation (SD) increase in log global methylation where methylation is a covariate. Physical activity (inactive, moderately inactive, moderately active, active) and annual income (<£15 000, £16-25 000, £26-35 000, £36-45 000, 4£45 000) were converted to scores (1-4 and 1-5, respectively) for inclusion in linear regression models, so that a regression coefficient for each of these characteristics is interpreted as the difference in the response associated with an increase of one level. Self-reported alcohol consumption in units per week was strongly right-skewed and the square root was used in regression models.
Results
Association between global methylation and socio-economic status In order to determine associations between levels of global DNA methylation and measures of SES and lifestyle factors, linear regression models were applied.
Two types of population characteristics were investigated: (i) age group (35-44, 45-54, 55-64 years), gender and deprivation group (most versus least deprived) and (ii) factors reflecting other aspects of SES and lifestyle, adjusted for age group, gender and deprivation group. The median global DNA methylation content within subgroups of SES and lifestyle factors, overall and by age group, is shown in Table 1 .
Regression analysis revealed an association between global DNA methylation content and age group, but not gender ( Table 2 ). The association with age group did not appear to reflect a decline of methylation content with increasing age, the lowest average methylation levels being found in the middle age group (45-54 years) and the highest in the oldest age group (55-64), 32% [95% confidence interval (CI) 10 to 59; P ¼ 0.003] higher than in the middle age group. Global DNA methylation content was 17% (95% CI 4 to 29; P ¼ 0.015) lower in the most deprived Figure 1A ). The proportion of variance in log DNA methylation content explained by age group, gender and SES, gauged by adjusted R 2 , was 4.3%, compared with 2.3% for age group and gender alone.
Moreover, manual workers had 24% (95% CI 8 to 38; P ¼ 0.005) lower levels of methylated DNA in comparison with non-manual workers, independently of age group, gender and deprivation group (Table 2, Figure 1B ). Social class, together with age group, gender and SES, explained 6.6% of the variation (adjusted R 2 ). A trend was observed between the number of years spent in education and global DNA methylation content, with each additional year of education being associated with 2.4% (95% CI À0.1 to 5.0; P ¼ 0.052) greater global DNA methylation content (Table 2, Figure 1C) . None of the other SES or lifestyle factors investigated had an influence on overall epigenetic status when considered independently of each other and in combination with age, gender and deprivation status.
To further investigate the role of SES confounding factors, regression models were adjusted to include income, diet score and current smoking status. As previously, a decrease in global DNA methylation content (27%) was noted within the manual workers group. However, the difference in average global DNA methylation content between deprived and affluent participants was substantially reduced, with deprived participants having 11% (95% CI À13 to 31; P ¼ 0.334) lower global DNA methylation content. The attenuation of the deprivation effect was further investigated by adjusting separately for income, diet and smoking status (in addition to age, gender and deprivation), which showed that this attenuation was entirely due to adjusting for income (95% CIs of the deprivation effect: À15% to 28% adjusted for income; 3 to 30% adjusted for diet; 4 to 32% adjusted for smoking status). None of the other factors investigated was associated with global DNA methylation content.
Association between global DNA methylation and biomarkers Linear regression analyses were performed to investigate associations between biochemical parameters and global DNA methylation content. As before, all analyses were adjusted for age, gender and These models were adjusted for age, gender and deprivation group alone (first column), or additionally for income, diet score and current smoking (second column).
deprivation group. The list of biomarkers analysed is displayed in Table 3 . IL-6 (pg/ml) and fibrinogen (g/l) levels were inversely associated with global DNA methylation content. A one-SD increase in log DNA methylation was associated with a 9% (95% CI 1 to 15; P ¼ 0.021) decrease in IL-6 levels and a 3% (95% CI 0 to 6; P ¼ 0.020) decrease in fibrinogen levels (Table 3) . Combining global DNA methylation content and a model that adjusts for gender, age group and deprivation group increased the adjusted R 2 from 20.3% to 21.8% where the outcome was log IL-6 level and from 6.5% to 8.2% where the outcome was log fibrinogen level.
Intriguingly, the greatest decrease in IL-6 (20% decrease for each additional SD of log global DNA methylation) was observed in the oldest age group (aged 55-64 years; P ¼ 0.003) whereas the largest decrease for fibrinogen (7%) was noted in the youngest group (aged 35-44 years; Table 4); however, there was no evidence to support an interaction between global DNA methylation content and age group. When the regression models were additionally adjusted for the lifestyle factors income, diet score and current smoking status, IL-6 levels decreased by 9% (95% CI 0 to 16; P ¼ 0.042) and fibrinogen levels decreased by 3% (95% CI 0 to 6; P ¼ 0.036); both remained associated with a one-SD increase in global DNA methylation (Table 3) . Adding these lifestyle factors slightly improved the models of both IL-6 level (adjusted R 2 were 19.9 and 21.1% without and with global DNA methylation, respectively) and fibrinogen level (adjusted R 2 were 9.2 and 10.7% without and with global DNA methylation, respectively).
Analyses were performed to establish which individual factors had an impact on IL-6 and fibrinogen expression. The association between increasing global DNA methylation content and decreasing IL-6 was strongest when analyses were adjusted for age and gender, a one-SD increase in log DNA methylation content being associated with a 13% decrease in IL-6 levels. This association was attenuated (P ¼ 0.007) to 9% with further adjustment for deprivation (Table 5) .
No further significant attenuation resulted from additional adjustment for income, diet and smoking status. Similarly, the strongest association (À4.0%) A B C Figure 1 Predicted DNA methylation (AE95% CI) in subgroups of (a) deprivation (affluent/deprived), (b) social class (Non-manual/manual) and (c) years of education (upper 50% / lower 50%), broken down by age group. P-values are given for test of equal geometric mean DNA methylation (indicated by horizontal lines) between subgroups. DNA methylation was predicted from linear regression models of log DNA methylation adjusted to a subject of average deprivation group (b and c only), age and gender between fibrinogen and global DNA methylation content was observed when analyses were adjusted for age and gender alone. This association was attenuated (P ¼ 0.019) to À3.4% by adjusting for deprivation status, with no further significant attenuation resulting from additional adjustment for income, diet and smoking status (Table 5) . Additionally, we found tentative evidence that the strength of association between global DNA methylation content and cholesterol levels varied between age groups (interaction P ¼ 0.011 for LDL cholesterol and P ¼ 0.055 for total cholesterol). The association was strongest in the oldest age group (55-64 years), with a one-SD increase in global DNA methylation being associated with an 11% (95% CI 2 to 20; P ¼ 0.011) increase in LDL cholesterol and a 6% (95% CI 0 to 12; P ¼ 0.043) increase in total cholesterol (Table 3) . These results are promising but are not sufficient to draw strong conclusions. A larger sample would be required to confirm these preliminary results for cholesterol and LDL cholesterol.
Discussion
We have observed that SES, lifestyle factors and a number of emerging biomarkers for CVD are associated with epigenetic status as measured by global DNA methylation content. Previous investigations seeking to determine such associations have yielded equivocal results, possibly as a result of difficulties in obtaining age-matched samples from SES groups. 16 Our study has demonstrated that global DNA hypomethylation was associated with the most deprived group of participants, when compared with the least deprived. This observation is further supported when other markers of SES are examined. Decreased global DNA methylation content was observed in manual workers, as opposed to nonmanual workers and a trend was observed with educational status. The extent of DNA hypomethylation in the most deprived group of participants is intriguing. Such global hypomethylation could be reflective of environmental exposures and/or diet during life, or a direct consequence of developmental programming in utero, or a combination of both. Notably, adjusting for diet does not weaken associations with global methylation status, suggesting that in utero programming or environmental factors would be causative for the observed global hypomethylation associated with lower SES. However, it must also be considered that poor reporting of diet may also play a role. This cohort does not present sufficient data points to determine whether fetal programming plays a major role, this would require further investigation in a larger study. A link with in utero programming is an attractive explanation, as there is some evidence supporting the effect of a poor childhood environment and an increased risk of cardiovascular disorders. Indeed, in utero epigenetic programming has been linked to the development of obesity, arteriosclerosis and diabetes and may be related to maternal diet and/or 'fuel economy'. 17, 18 This is pertinent to a Glasgow-based cohort, where persistence of socio-economic deprivation can be invoked to explain specific global DNA hypomethylation, with consequent effects on health in adult life. Such a scenario is consistent with the high prevalence of CVDs observed within Glasgow being associated with socio-economic and lifestyle factors.
Our study supports a relationship between global DNA methylation and emerging biomarkers of CVD and systemic inflammation. We have observed an association between hypomethylation and increased expression of biomarkers of CVD, such as IL-6. Conversely, a relative elevation of global DNA methylation content was associated with higher total cholesterol and LDL levels in the oldest group (55-64 years). This association was further enhanced when the analysis was adjusted for deprivation status, income, diet and smoking status. These findings are supported by the results of previous studies, using the same cohort, whereby higher total cholesterol and LDL levels were shown to be associated with deprivation status and biological age. 14, 19 Other studies have suggested that DNA hypomethylation may be a result of CVD risk factors, 20 whereas yet others suggest it is a causative agent. 21, 22 Several studies have suggested the mechanism for the latter may be hyperhomocysteinemia. 23, 24 We also observed that the association of methylation content with age group did not appear to reflect a decline of methylation content with increasing age, which has been reported by other groups, 25, 26 as the lowest average methylation levels were found in the middle age group (45-54 years) and the highest in the oldest age group (55-64 years). This is intriguing and requires further study. It may reflect the influence of SES confounding factors and survivor effects in this particular cohort. Alternatively, this may be due to other large environmental events that took place at specific points in history, perhaps early childhood for each group; such events could include disease or environmental disasters.
At a mechanistic level, our observations may be explained by lipid-and lipoprotein-induced DNA instability and chromatin remodelling, through changes in genomic DNA methylation content resulting in aberrant gene expression. Recent studies have revealed that free intracellular cholesterol can associate with chromatin as a complex with sphingomyelin, other lipids and an as yet unidentified protein. 27 
Table 4
Percentage difference (95% CI) in biomarker level associated with an increase of one SD in log DNA methylation Outcomes Predicted per cent difference (95% CI) in biomarker level, adjusted for: These models were adjusted for age group, gender and deprivation group alone (first column), or additionally for income, diet score and current smoking (second column). Age þ gender þ deprivation þ income þ diet þ current smoking À3.0 (À5.8, to À0.2), 0.036 0.694
P-values for change in the DNA methylation effect estimate due to each additional adjustment were estimated from 10 000 bootstrap samples. Due to missing data in some covariates, all models were fitted on a reduced data set of 217 participants.
